Secura Bio
PrivateLast Round
Debt
Mar 5, 2019
Total Funding Raised
$145M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Secura Bio is a biopharmaceutical company that develops and commercializes oncology therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Secura Bio Comparables
Compare Secura Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Yingli Pharmaceutical Co., Ltd. | 79% | |
| AbbVie | 77% | |
| TG Therapeutics | 77% | |
Secura Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 5, 2019 | ||||
| Early Funding | Mar 5, 2019 |
Secura Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Athyrium Capital Management | Debt, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 60, 103% of headcount.
- Jul 25, 2026
Monthly visitors grew 77% MoM.
Secura Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Secura Bio's valuation, stock price, and market status.